Produced in collaboration with the Joslin Diabetes Center This activity is supported by an educational grant from Sanofi US.
Your Type 2 diabetes can change over time, so it is very important that your treatments keep up with the changes in your body. There are many newer treatments available today like long-acting insulins, and they can seem confusing at first. But for many people, they can make a big difference.
Don’t get bogged down in confusion and fears: learn more about these new long-acting insulin treatments and if they might be right for you. Log-in to an easy-to-understand, interactive video session with top clinicians from the world-renowned Joslin Diabetes Center, and one of their patients to empower yourself with trustworthy information.
This three-part program covers:
- How long-acting insulin treats Type 2 diabetes at different stages of this condition
- The benefits of different insulin options, and the real story about side effects for each
- Talking to your care team about long-acting insulins to see if they are right for you
Richard S. Beaser, MD
Joslin Diabetes Center
Richard S. Beaser, M.D., is a practicing physician in the Joslin Clinic and holds the position of Associate Clinical Professor of Medicine at Harvard Medical School. He has also been the Medical Executive Director of Professional Education at Joslin and was instrumental in developing that activity at Joslin, a department he founded in 1990. Dr. Beaser graduated in 1973 from Trinity College, Hartford, and received his medical degree from Boston University School of Medicine in 1977. He served as a resident in internal medicine at the University of Massachusetts Medical Center in Worcester from 1977-1980. He was a fellow in endocrinology at the Joslin Diabetes Center, Boston, MA 1980-81, and in Endocrinology at the Lahey Clinic Medical Center, Burlington, MA 1981-82. Dr. Beaser has been on the staff of the Joslin Diabetes Center since 1982. He has held numerous past positions at Joslin, including Section Chief of the Adult Diabetology Practice, Medical Director of the Diabetes Treatment Unit, Coordinator of the Patient Education Section, and Medical Director of Joslin TrialNet, a clinical trials network. He has been a clinical research investigator, including the landmark Diabetes Control and Complications Trial. Dr. Beaser has authored 4 books: Joslin Diabetes Manual, Outsmarting Diabetes, The Joslin Guide to Diabetes, and Joslin’s Diabetes Deskbook: A Guide for Primary Care Providers. Dr Beaser is a well-known national lecturer on clinical diabetes and its comorbidities. He is the author of numerous publications in peer review journals, review articles, and book chapters. In his role as Medical Executive Director of Professional Education at Joslin Diabetes Center, and currently as the Chair of the CME Committee, Dr. Beaser has a specific focus on development or oversight of educational content for the department, targeting physicians, other medical professionals, and patients. He leads departmental conceptualization and development of projects and activities.
Lyle D. Mitzner
Joslin Diabetes Center
Lyle D. Mitzner, MD, is a clinician educator at the Joslin Clinic and an assistant professor of medicine at Harvard Medical School in Boston, Massachusetts. Additionally, he is an endocrinology consulting physician at Beth Israel Deaconess Medical Center and New England Baptist Hospital, also located in Boston. Dr Mitzner is board-certified by the American Board of Internal Medicine with a subspecialty in endocrinology, diabetes and metabolism. He received his medical degree from the Albert Einstein College of Medicine, Yeshiva University in Bronx, New York, completed a residency in internal medicine at Beth Israel Deaconess Medical, followed by a fellowship in endocrinology, diabetes and metabolism at Yale-New Haven Medical Center in Connecticut.
Mary Paschal, RN, MS, CDE
Mary Paschal, RN, MS, CDE, is registered nurse and certified diabetes educator at the Joslin Diabetes Center in Needham, Massachusetts. She specializes in diabetes self-management for adult patients with type 1 and type 2 diabetes, including insulin pump therapy and continuous glucose monitoring. She is the program manager responsible for maintaining a recognized certified educational program providing optimal outcomes for patients living with diabetes. Ms Paschal completed her undergraduate and graduate degrees at Boston College in Boston, Massachusetts.